{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:19:30Z","timestamp":1780478370250,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004843","name":"Manipal University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.biopha.2017.09.150","type":"journal-article","created":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T16:53:23Z","timestamp":1509987203000},"page":"736-741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Sodium valproate enhances doxorubicin-induced cognitive dysfunction in Wistar rats"],"prefix":"10.1016","volume":"96","author":[{"given":"Thaneshwar","family":"Verma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanchari Basu","family":"Mallik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.V.","family":"Ramalingayya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawan G.","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoop","family":"Kishore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Sreedhara R.","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnadas","family":"Nandakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.biopha.2017.09.150_bib0005","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.neubiorev.2013.04.015","article-title":"Chemobrain: a systematic review of structural and functional neuroimaging studies","volume":"37","author":"Sim\u00f3","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2017.09.150_bib0010","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3109\/09540261.2013.864260","article-title":"Prevalence, mechanisms, and management of cancer-related cognitive impairment","volume":"26","author":"Janelsins","year":"2014","journal-title":"Int. Rev. Psychiatry"},{"issue":"6","key":"10.1016\/j.biopha.2017.09.150_bib0015","first-page":"W32","article-title":"Measuring patient self-reported cognitive function: development of the functional assessment of cancer therapy-cognitive function instrument","volume":"7","author":"Wagner","year":"2009","journal-title":"J. Support Oncol."},{"issue":"10","key":"10.1016\/j.biopha.2017.09.150_bib0020","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1038\/bjc.1996.608","article-title":"What do cancer patients mean when they complain of concentration and memory problems?","volume":"74","author":"Cull","year":"1996","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2017.09.150_bib0025","article-title":"Cancer-and cancer treatment\u2013associated cognitive change: an update on the state of the science","volume":"43","author":"Ahles","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2017.09.150_bib0030","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cyto.2014.12.006","article-title":"Chemobrain: a critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapy","volume":"72","author":"Wang","year":"2015","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.biopha.2017.09.150_bib0035","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10549-007-9686-5","article-title":"Cognitive function in breast cancer patients prior to adjuvant treatment","volume":"110","author":"Ahles","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"issue":"11","key":"10.1016\/j.biopha.2017.09.150_bib0040","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1002\/cncr.20272","article-title":"The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma","volume":"100","author":"Wefel","year":"2004","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2017.09.150_bib0045","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.neubiorev.2010.09.006","article-title":"Neurobiological basis of chemotherapy-induced cognitive impairment: a review of rodent research","volume":"35","author":"Seigers","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2017.09.150_bib0050","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejcsup.2013.07.007","article-title":"Chemotherapy-related changes in cognitive functioning","volume":"11","author":"Schagen","year":"2013","journal-title":"Eur. J. Cancer Suppl."},{"issue":"4","key":"10.1016\/j.biopha.2017.09.150_bib0055","first-page":"831","article-title":"Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research","volume":"20","author":"Janelsins","year":"2012","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.biopha.2017.09.150_bib0060","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bbr.2015.06.028","article-title":"Doxorubicin and cyclophosphamide induce cognitive dysfunction and activate the ERK and AKT signaling pathways","volume":"292","author":"Salas-Ramirez","year":"2015","journal-title":"Behav. Brain Res."},{"issue":"6","key":"10.1016\/j.biopha.2017.09.150_bib0065","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.neuron.2004.06.002","article-title":"CBP histone acetyltransferase activity is a critical component of memory consolidation","volume":"42","author":"Korzus","year":"2004","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.biopha.2017.09.150_bib0070","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.coph.2007.12.002","article-title":"Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders","volume":"8","author":"Abel","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"issue":"39","key":"10.1016\/j.biopha.2017.09.150_bib0075","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2017.09.150_bib0080","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/sj.mp.4002099","article-title":"The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons","volume":"14","author":"Yasuda","year":"2009","journal-title":"Mol. Psychiatry"},{"issue":"11","key":"10.1016\/j.biopha.2017.09.150_bib0085","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.tins.2009.06.002","article-title":"Multiple roles of HDAC inhibition in neurodegenerative conditions","volume":"32","author":"Chuang","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.biopha.2017.09.150_bib0090","first-page":"2","article-title":"Hyper-connectivity and hyper-plasticity in the medial prefrontal cortex in the valproic acid animal model of autism","author":"Rinaldi","year":"2008","journal-title":"Front. Neural Circuits"},{"issue":"6","key":"10.1016\/j.biopha.2017.09.150_bib0095","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/1440-1681.12568","article-title":"Assessment of female rats for studying episodic memory and its deficit associated with doxorubicin-induced chemobrain","volume":"43","author":"Grandhi","year":"2016","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2017.09.150_bib0100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0304-4165(79)90289-7","article-title":"Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver","volume":"582","author":"Moron","year":"1979","journal-title":"Biochimica et Biophysica Acta (BBA)-Gen Subj."},{"key":"10.1016\/j.biopha.2017.09.150_bib0105","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neulet.2016.08.044","article-title":"Caffeic acid attenuates lipopolysaccharide-induced sickness behaviour and neuroinflammation in mice","volume":"632","author":"Mallik","year":"2016","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.biopha.2017.09.150_bib0110","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/(SICI)1099-1573(200005)14:3<174::AID-PTR624>3.0.CO;2-O","article-title":"Antioxidant activity ofBacopa monniera in rat frontal cortex, striatum and hippocampus","volume":"14","author":"Bhattacharya","year":"2000","journal-title":"Phytother. Res."},{"issue":"1","key":"10.1016\/j.biopha.2017.09.150_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2202-12-124","article-title":"Chemotherapy-induced cognitive impairment is associated with decreases in cell proliferation and histone modifications","volume":"12","author":"Briones","year":"2011","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.biopha.2017.09.150_bib0120","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/978-1-4419-6306-2_19","article-title":"Chemo brain (chemo fog) as a potential side effect of doxorubicin administration: role of cytokine-induced, oxidative\/nitrosative stress in cognitive dysfunction","author":"Aluise","year":"2010","journal-title":"Chemo Fog: Springer"},{"issue":"3","key":"10.1016\/j.biopha.2017.09.150_bib0125","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrc2073","article-title":"Candidate mechanisms for chemotherapy-induced cognitive changes","volume":"7","author":"Ahles","year":"2007","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.biopha.2017.09.150_bib0130","doi-asserted-by":"crossref","first-page":"e11383","DOI":"10.1371\/journal.pone.0011383","article-title":"Valproate administered after traumatic brain injury provides neuroprotection and improves cognitive function in rats","volume":"5","author":"Dash","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2017.09.150_bib0135","first-page":"2015","article-title":"Valproic acid neuroprotection in the 6-OHDA model of Parkinson\u2019s disease is possibly related to its anti-inflammatory and HDAC inhibitory properties","author":"Ximenes","year":"2015","journal-title":"J. Neurodegener. Dis."},{"key":"10.1016\/j.biopha.2017.09.150_bib0140","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.neuroscience.2012.06.012","article-title":"Valproic acid increases white matter repair and neurogenesis after stroke","volume":"220","author":"Liu","year":"2012","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.biopha.2017.09.150_bib0145","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3390\/nu8050303","article-title":"Asiatic acid prevents the deleterious effects of valproic acid on cognition and hippocampal cell proliferation and survival","volume":"8","author":"Umka Welbat","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2017.09.150_bib0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2013.03.018","article-title":"Mitochondrial diseases of the brain","volume":"63","author":"Chaturvedi","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.biopha.2017.09.150_bib0155","doi-asserted-by":"crossref","first-page":"307","DOI":"10.14336\/AD.2015.1022","article-title":"The role of oxidative stress in etiopathogenesis of chemotherapy induced cognitive impairment (CICI)-chemobrain","volume":"7","author":"Gaman","year":"2016","journal-title":"Aging Dis."},{"issue":"6","key":"10.1016\/j.biopha.2017.09.150_bib0160","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4196\/kjpp.2010.14.6.435","article-title":"Neuroprotection by valproic acid in mouse models of permanent and transient focal cerebral ischemia","volume":"14","author":"Qian","year":"2010","journal-title":"Korean J. Physiol. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2017.09.150_bib0165","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1089\/neu.2013.3146","article-title":"Valproic acid protects motor neuron death by inhibiting oxidative stress and endoplasmic reticulum stress-mediated cytochrome C release after spinal cord injury","volume":"31","author":"Lee","year":"2014","journal-title":"J. Neurotrauma"},{"issue":"5","key":"10.1016\/j.biopha.2017.09.150_bib0170","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1471-4159.2012.07731.x","article-title":"Valproic acid attenuates blood-spinal cord barrier disruption by inhibiting matrix metalloprotease-9 activity and improves functional recovery after spinal cord injury","volume":"121","author":"Lee","year":"2012","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.biopha.2017.09.150_bib0175","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3390\/ijms18051048","article-title":"Valproic acid induces endocytosis-mediated doxorubicin internalization and shows synergistic cytotoxic effects in hepatocellular carcinoma cells","volume":"18","author":"Saha","year":"2017","journal-title":"Int. J. Mol. Sci."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333221732913X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333221732913X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:27:52Z","timestamp":1778243272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333221732913X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":35,"alternative-id":["S075333221732913X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.09.150","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sodium valproate enhances doxorubicin-induced cognitive dysfunction in Wistar rats","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.09.150","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}